RxDoctor Payments Data

Chee Hung, MD

Interventional Pain Medicine · Clinton, MDNPI 1861423212

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Electronic Waveform Lab, Inc. at 45.8% of the total. Reporting peaked in 2019 at $253 and has fallen 64.1% since, to $91 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in MD, where the typical reported total is $3,506.

$963in general payments, 2019–2025

Across 18 payments — averaging $53.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Electronic Waveform Lab, Inc.$441
  • SPR Therapeutics, Inc$158
  • Spark Therapeutics, Inc.$92
  • Aerin Medical Inc.$91
  • Scilex Pharmaceuticals Inc.$70
  • Kowa Pharmaceuticals America, Inc.$56
  • plus $55 from 2 others

What the payments were for

  • Food & beverage$963100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$963 in reported general payments places this provider in the 10th percentile of 56 interventional pain medicine providers in Maryland.

See all interventional pain medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$101,979
Medicare patients
269
Services billed
833

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine24$5,845
Gabapentin156$4,384
Celecoxib56$3,234
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen158$3,218
Oxycodone Hcl156$2,151
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen50$2,142
Tizanidine Hcl76$1,980
Duloxetine Hcl64$1,383
Tramadol Hcl160$1,368
Acetaminophen-CodeineAcetaminophen With Codeine51$1,046
Oxcarbazepine18$857
Pregabalin34$840
Cyclobenzaprine Hcl56$783
Diclofenac Sodium42$675
Methocarbamol26$669

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Clinton

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →